Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment have?
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment has 24 citations in the OpenAlex counts ScholarIQ stores.
When was Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment published?
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment has 2024 year in the ScholarIQ index.
What is the open-access status of Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment?
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment has green oa status in the ScholarIQ index.
What is the DOI of Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment?
The DOI for Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment is on the source record.
What is the PMID of Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment?
The PMID for Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment is on the source record.
What is the OpenAlex record for Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment?
The OpenAlex for Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment is on the source record.